医学新知杂志2008年第18卷第4期
231
[J].诊断病理学杂志,2000,7(3):175-177.4
YaoGY,ZhouJL,LaiMD,etal.Neuroendocrinemarkersinadenocarcinoma:aninvestigationof356cases[J].WorldJGastroenterol,2003,9(4):860-861.5HuangJ,YaoJL,diSant'AgnesePA,etal.Immuno-histochemicalcharacterizationofneuroendocrinecells
inprostatecancer[J].Prostate,2006,66:1125-1135.6KamiyaN,AkakuraK,SuzukiH,etal.Pretreatment
serumlevelofneuronspecificenolase(NSE)asaprognosticfactorinmetastaticprostatecancerpatientstreatedwithendocrinetherapy[J].EuropeanUrology,2003,44(3):309-314.
7YangXD,WangS,MengHY,etal.Theprognosisvalue
ofhumanneuroendocrinecloneoncolorectalcarcinoma[J].ZhonghuaWaiKeZaZhi,2005,43(11):706-709.8AtasoyP,BozdoganO,OzturkS,etal.Bcl-2expression
anditscorrelationwithneuroendocrinedifferentiationincoloncarcinomas[J].Tumori,2004,90(2):233-238.9何松,严桥,陈旭东,等,胃癌细胞中神经内分泌分化与术
后生存关系的研究[J].中国肿瘤临床,2007,34(22):1283-1286.10AbdulM,HooseinN.Relationshipoftheinterleukin-1
systemwithneuroendocrineandexocrinemarkersinhumancoloncancercelllines[J].Cytokine,2002,18:86-91.11KimJ,AdamRM,SolomKR,etal.Involvementof
cholesterolrichlipidraftsIninterleukin-6-inducedneu-roendocrinedifferentiationofLNCaPprostatecancercells[J].Endocrinol,2004,145(2):613-619.
12ZieglerCG,SicardF,LattkeP,etal.Dehydroepiandrosterone
inducesaneuroendocrinephenotypeinnervegrowthfactor-stimulatedchromaffinpheochromocytomaPC12cells.Endocrinology[J].2008,149(1):320-8.
13Gutierrez-CanasI,JuarranzMG,ColladoB,etal.
VasoactiveintestinalpeptideinducesneuroendocrinedifferentiationintheLNCaPprostatecancercelllinethroughPKA,ERK,andP13K[J].Prostate,2005,63(1):44-55.14kumarB,HarsonAJ,PrasadKN.Sensitivityofproteasome
toitsinhibintorsincreaseduringcAMP-induceddif-ferentiationofneuroblastomacellsincultureandcausesdecreasedviability[J].CancerLett,2004,204(1):53-59.15SpiottoMT.STAT3mediatesIL-6-inducedneuroendocrine
differentiationinprostatecancercells[J].Prostate,2000,42(3):186-195.16GoodinJL,RutherfordCL.Characterizationofhuman
ribosomalS3ageneexpressionduringadenosine3':5'cyclicmonophosphateinducedneuroendocrinedif-ferentiationofLNCaPcells:RegulationofS3ageneexpressioninLNCaP[J].MolecularBiologyReports,2002,29(3):301-316.
17KimKM,KimMJ,ChoBK,etal.Geneticevidence
forthemultistepprogressionofmixedglandular-neu-roendocrinegastriccarcinoma[J].VirchowArch,2002,440(1):85-93.
(收稿日期:2008-02-26)
(编辑:朱利武)
(上接第228页)423-428.
10ScottQH,PatrickDS,HeX.Davidon:RNAinterference
improvesmotorandneuropathologicalabnormalitiesinaHuntington'sdiseasemousemode[J].PNAS,2005,19,102(16):5820-5825.
11SalviA,AriciB,DePG.SmallinterferingRNAurokinase
siliencingingibiesainvasionandmigrartionofhumanheparocellularcarcinomacells[J].MolCancerTher,2004,3(6):671-678.
12TsujiN,AsanumaK,KobayashiD.Introductionofa
survivingene-specificsmallinhibitoryRNAinhibitsgrowthofpancreaticcancercells[J].AnricancerRes,2005,25(6B):3967-3972.
13MiyagishiM,MatsumotoS.EdRNAinterferencetechnology
[J].BasicSciencetoDrugDevelopment,2005,12:480-496.14NovinaCD,MurrayMF,DykxhoornDM.SiRNA-directedinhibitionofHIV-1infection[J].NatureMedicine,2002,8(7):681-686.
15AkashiH,MatsumotoS,TairaK.Genediscoveryby
ribozymeandsiRNAlibraries[J].NatRevMolCellBiol,2005,(6):413-422.
16SchiffelersRM,XuJ,StormG.Effectsoftreatment
17
18
19
20
withsmallinterferingRNAonjointinflammationinmicewithcillagen-inducedarthritis[J].Rheum,2005,52(4):1314-1318.
SchmitzV,NeumanUP,FischerU.Inductionoflong-termgraftacceptancebyacombiunationtreatmengtofdonorsplenocytesandCTLA4Iginahighresponderratlivertransplantationmodel[J].TransplInt,2005,18(10):1187-1196.
TomasoniS,LongarettiL,AzzolliniN.FavorableeffectofcotransfectionwithTGF-betaandCTLA4Igofthedonorkidneyonallograftsurvival[J].AmJNephrol,2004,24(3):275-283.
MalmH,PahlmanC,VeressB.Combinedcosrimulationblockadepreventsrejectionofallogeneicisletsinmice[J].ScandJImmunology,2006,64(4):398-403.
BigenzahnS,BlahaP,KoporcZ.Theroleofnon-deletionaltolerancemechanisminamurinemodelofmixedchimerismwithcostimulationblockade[J].AmJTransplant,2005,5(6):1237-1247.
(收稿日期:2008-04-03)(编辑:李瑞芳)
卵巢上皮性肿瘤的神经内分泌分化及其机制初探_专业资料。目的 初步探讨卵巢上皮...(1)卵巢上皮性肿瘤中CgA表达阳性率59.4%,Syn表达阳性率65.36%,在恶性肿瘤其...
2神经内分泌分化细胞的起源 目前对恶性肿瘤NED的临床意义和机制,在前列腺 癌,乳腺癌、肺癌巾研究较多,而对结直肠癌NED的研究报道较少。1 对NED细胞的组织起源有...
(神经内分泌肿瘤=类癌) NEN:缓慢生长低度恶性——高转移的高度恶性 神经内分泌...? ? 肿瘤分化差,呈巢状、小梁状,可有器官样、菊形团 或栅栏状结构 癌细胞...
NET的组织学分类1 分化与分级 分化好 类癌, 胰岛细胞, 胰腺 (神经) NET, ...和神经内分泌肿瘤形态特点的上皮性肿瘤,每种成分至少 各占肿瘤的30%,均为恶性...
神经分泌颗粒,在生物学行为和疗效方面 存在不同,包括从具有良好预后到高度恶性...消化系统神经内分泌肿瘤的分化是一个循序渐进的过程: 内分泌细胞增生-异型增生-...
老年男性伴神经内分泌分化乳腺癌1例_基础医学_医药卫生_专业资料 暂无评价
低分化腺癌鉴别, 免疫组织化学 NSE、CHG2A 均阳性, 可以肯定为神经内分泌肿瘤。...结合大体、组织形态及其临床高度恶性的生物学 行为, 可以诊断胃神经内分泌癌。 ...
能产生肽类激素的肿瘤并 且具有神经内分泌标记物 包括高分化肿瘤和低分化肿瘤 ...替莫唑胺、贝伐珠单抗和长效奥曲肽 联合应用治疗恶性神经内分泌肿瘤 ? 在多种...
分化差 vs 分化良好 ? 肿瘤分级 (G1, G2, G3即NEC) ? 良性 vs 恶性 ...胃肠胰神经内分泌肿瘤,2011,CSCO GEP NET专业委员会成立大会 小细胞NEC镜下特点...
在类癌、嗜铬细胞瘤、 恶性黑色素瘤、神经母细胞瘤、肺小细胞癌和各种内分泌...可呈阳性反应, 这样的结果可能与肿瘤 细胞的异质性(肿瘤向神经内分泌分化)有关...
热门文档